
Sign up to save your podcasts
Or
Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
4.3
229229 ratings
Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
9,108 Listeners
8,497 Listeners
1,879 Listeners
992 Listeners
2,856 Listeners
1,016 Listeners
7,711 Listeners
1,012 Listeners
3,457 Listeners
1,379 Listeners
19,711 Listeners
10,635 Listeners
5,657 Listeners
53 Listeners
2,264 Listeners
2,042 Listeners
23,948 Listeners
10,071 Listeners
554 Listeners
6,724 Listeners
2,392 Listeners
1,286 Listeners
5,390 Listeners
1,187 Listeners
414 Listeners
5,374 Listeners
15,298 Listeners
59 Listeners
46 Listeners
95 Listeners
4 Listeners
89 Listeners